LCN2 and infection: Given that Lcn2 regulates iron metabolism, innate immunity, and neutrophil function, systemic inhibition may disrupt iron homeostasis or increase infection risk, highlighting the need to determine an optimal post-SAH treatment window that balances early neuroprotection with preservation of iron clearance and tissue repair.